Is E3 Lithium a buy?

Roth Capital Markets analyst Joe Reagor reaffirmed his “Buy” rating and C$3.00 target price for E3 Lithium (E3 Lithium Stock Quote, Chart, News, Analysts, Financials TSXV:ETL) in a Sept. 25 note, following the company’s announcement that it has produced battery-grade lithium carbonate from Phase 1 of its Alberta demonstration plant.

“We view this update as an incremental but anticipated positive,” he said. “We continue to look to Phases 2 and 3 of the demonstration plant as being more significant derisking events.”

On Sept. 22, E3 reported the Phase 1 success, which validates that the demonstration facility’s equipment is functioning as designed. Data from the process will also feed into a feasibility study slated for 2026.

Reagor emphasized that Phase 2, where fresh brine will be processed through the 30-column plant at a new site, will provide further validation of the technology. Phase 3, involving the construction of a commercial-scale column, is expected to mark the most critical de-risking milestone, supporting project financing with proof-of-concept at scale.

Reagor said that while Phase 1 is encouraging, investors are likely to place more weight on the outcomes of Phases 2 and 3.

“Phase 3 should provide the biggest de-risking event for the company to date as it should significantly reduce risks related to scaling up the project and allow for project financing to be supported by proof of concept at commercial scale,” he said.

Founded in 1998 and headquartered in Calgary, E3 Lithium is developing its Alberta Lithium Project by extracting lithium from brines using infrastructure tied to the province’s oil and gas sector.

 

-30-

Tagged with: ETL
Tara Whittet

Tara Whittet is Senior Sales Manager at Cantech Letter.

Recent Posts

An interest rate hike in 2026 is unlikely, RBC says

RBC economist Abbey Xu noted that Canadian inflation edged higher in September, driven largely by rising energy prices, although there… [Read More]

13 hours ago

Two Canadian healthtech stocks analysts like right now

Artificial intelligence is opening new opportunities in healthcare, and Bessemer Venture Partners argues that public markets have yet to fully… [Read More]

13 hours ago

Itron is an undervalued stock, this analyst says

Roth Capital Partners analyst Chip Moore reiterated his “Buy” rating and US$136.00 target on Itron (Itron Stock Quote, Chart, News,… [Read More]

13 hours ago

Village Farms is a “significantly undervalued” stock, analyst says

Beacon Securities analyst Doug Cooper reiterated his “Buy” rating and US$8.00 target on Village Farms International (Village Farms International Stock… [Read More]

13 hours ago

Can Eli Lilly keep going up?

StoneCastle Investment Management president and portfolio manager Bruce Campbell says Eli Lilly (Eli Lilly  Stock Quote, Chart, News, Analysts, Financials… [Read More]

13 hours ago

Carrier Connect Data Solutions: this analyst just hiked his target

Beacon Securities analyst Gabriel Leung raised his target on Carrier Connect Data Solutions (Carrier Connect Data Solutions  Stock Quote, Chart,… [Read More]

1 day ago